The 2024 CDTR Pilot & Feasibility Application Cycle is Now Open
Purpose: The purpose of this program is to promote innovative and transformative research, by investigators new to the field, to advance health equity in diabetes. The pilot and feasibility program focuses on T2-T4 translational research defined as ‘translating interventions and approaches that have demonstrated efficacy into real-world healthcare settings, communities, and diverse populations with an emphasis on reach, sustainability, and potential for widespread implementation’.
Two levels of funding are available for applicants:
- Pilot Grants: provide up to $50,000 direct costs for one year to facilitate the planning of a new clinical and/or translational research project.
- Small Projects (accepted on a rolling basis): This $5,000 funding opportunity will support highly-focused data collection, secondary- or other analyses relevant to the WU-CDTR mission. Small project application can be found here.
Application Timeline
| Applications Open: | September 3, 2024 |
| Letter of Intent Due: | November 4, 2024 |
| Full Proposals Due: | December 2, 2024 |
| Earliest Project Start Date: | March 1, 2025 |
Need assistance developing your proposal? Contact us at cdtr@wustl.edu